News

GMOs: Scientific or Social Uncertainty?

GMOs: Scientific or Social Uncertainty?

Genetic engineering is the process of altering the blueprints of an organism in order to effect some desired change. Since its discovery in the 1970s, this technology has been used to advance research, industry, medicine, and agriculture.

CBR Magazine November 2018

CBR Magazine November 2018

2018 November Magazine for Website by CBR on Scribd

Proteases can be a turn-on, or a turn-off. Or… A Protease-mediated Switch Controls the Transition from Proinflammatory (M1) to Repair (M2) Macrophages

Proteases can be a turn-on, or a turn-off. Or… A Protease-mediated Switch Controls the Transition from Proinflammatory (M1) to Repair (M2) Macrophages

Chronic inflammatory & autoimmune diseases affect many Canadians, and yet the mechanisms behind such conditions are not fully understood and there is no cure available.

Open Access and Open Science: The Call for More Transparency in Science

Open Access and Open Science: The Call for More Transparency in Science

In May of this year, a group of Swedish universities made the decision not to renew their contracts with publishing giant Elsevier. To researchers who rely on these journals for their day-to-day work this may seem like a drastic move, but this new stand-off is part of a movement toward an open-access model in publishing research.

CBR Summer Students Visit Canadian Blood Services!

CBR Summer Students Visit Canadian Blood Services!

What is involved in getting blood that has been donated at a mobile clinic in Campbell River to a patient on the operating table at Vancouver General Hospital?

The Bayer-UBC Bleeding Disorders Collaboratory Continues to Innovate

The Bayer-UBC Bleeding Disorders Collaboratory Continues to Innovate

The Bayer-UBC Bleeding Disorders Collaboratory, established in 2012 with a $750,000 financial commitment from Bayer Inc., has stimulated substantial innovation in the treatment of hemophilia and other bleeding disorders.

The First Targeted Gene Therapy Approved in North America: Luxturna

The First Targeted Gene Therapy Approved in North America: Luxturna

RPE65-mediated inherited retinal dystrophy leads to severe deterioration of vision and complete blindness in early adulthood. A small subgroup of patients, approximately 1000 people in the United States, have mutations in both paternal and maternal copies of the RPE65 gene that encodes retinoid isomerohydrolase.

31st Annual Canadian Society for Immunology Meeting

31st Annual Canadian Society for Immunology Meeting

Thanks to the Centre for Blood Research for providing me with the CBR Postdoctoral Fellow Travel Award. Because of this travel award, I had the opportunity to attend the 31st Annual Canadian Society for Immunology Meeting (CSI) for the first time.

2018 Michael John Page Postdoctoral Fellow Award

2018 Michael John Page Postdoctoral Fellow Award

On Wednesday October 17th, Dr. Jennifer Grants was presented with the 2018 Michael John Page Postdoctoral Fellow Award by the Department of Biochemistry & Molecular Biology (BMB) and the Centre for Blood Research (CBR).

Building Resilience in Graduate School

Building Resilience in Graduate School

When I started graduate school at UBC in 2012, I thought I was prepared. I had excellent marks, publications from research done as an undergraduate student, and even an NSERC award.